Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030162238 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
08/28/2003US20030162230 Measurement phosphorylation of protein
08/28/2003US20030162229 Immuno-interactive fragments of the alpha-C subunit of inhibin
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay
08/28/2003US20030161837 Crosslinking an immunoglobulin or fragment thereof with anN-hydroxyl-succinimide ester and a maleimide linked vis a polyethyleneoxide spacer and incubating with a polypeptide having a sulfhydryl group (an allergen or autoantigen)
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161832 Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate specific membrane antigen
08/28/2003US20030161828 Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure
08/28/2003US20030161827 Therapies that improve graft survival
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161813 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
08/28/2003US20030161809 Complexes; drug delivery
08/28/2003CA2480771A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
08/28/2003CA2477202A1 Cd40 splice variants, compositions for making and methods of using the same
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476835A1 A non-invasive diagnostic test utilizing histone modification markers
08/28/2003CA2476832A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2418780A1 Synthetic genes encoding proteins of porcine reproductive and respiratory syndrome virus and use thereof
08/27/2003EP1338896A2 ICAM-4 and diagnostic uses thereof
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338655A1 Substance inhibiting the binding of signal transducing molecule to kdr/flk-1 phosphorylated at tyrosine at the 1175-position and method of using the same
08/27/2003EP1338607A2 Antigenic iron repressible proteins from n. meningitidis related to the heolysin family of toxins
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337663A2 Determination of the ability of patients to respond to tumour treatment
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337638A2 Adipocyte complement related protein zacrp13
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof
08/27/2003EP1337561A1 Probes for identifying cancer-specific antigens
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337546A2 Method for detecting hematopoietic stem cells
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1110086A4 Production of motif-specific and context-independent antibodies using peptide libraries as antigens
08/27/2003EP1046036A4 Methods for obtaining probes of peptide function
08/27/2003EP1042368B1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
08/27/2003EP0932625B1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
08/27/2003EP0832132B1 Lymphocyte chemoattractant factor and uses thereof
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0702793B1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation
08/27/2003EP0670849B1 Diagnostic assay for latent matrix metalloproteinase no. 9
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1438896A Vaccine comprising a tick cement protein
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438247A Anti-mastitis causative-agent composite yolk antiboy for milk cow and its preparation and use
08/27/2003CN1438246A Anti-yellow-dysenteryÒÇüanti-white-dysentery causative-agent yolk antibody for young pig and its preparation and use
08/27/2003CN1438245A Infectious causative-agent related egg-yolk antibody preparation and use thereof
08/27/2003CN1438244A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610630 Selectivity adsorption immunoglobulins
08/26/2003US6610527 The taxadiene synthase gene of Pacific yew has been cloned and its nucleic acid and polypeptide sequence is presented. Truncation or removal of the transit peptide increases expression of the cloned taxadiene synthase gene expression in
08/26/2003US6610526 Human E1-like protein
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610513 Receptor proteins
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610507 Polynucleotides encoding patched proteins
08/26/2003US6610505 Oncoprotein protein kinase
08/26/2003US6610502 2-amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid; to a method for testing a biological function by quantitating 2- amino-3-(2-( alpha -mannopyranosyl)indole-3-yl)propionic acid in a collected
08/26/2003US6610501 Porcine protein and uses thereof
08/26/2003US6610500 Agonistic anti-human TrkA mAb 5C3 which recognizes the NGF docking site. Such antibodies may be used for the treatment, diagnosis or prevention of neurological diseases, neuromas and neoplastic tumors which express TrkA receptors.
08/26/2003US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide
08/26/2003US6610485 Kit are provided for selectively isolating genes encoding membrane-bound proteins by fusing proteins to a secretable protein having a binding affinity to an antigen (e.g.an antibody), expressing these fusions in host cells, and
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610476 Nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant,DNA methods and production of viral RNA are disclosed. Such polypeptides can
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610472 Assembly and screening of highly complex and fully human antibody repertoire in yeast
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610299 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610295 HCMV glycoproteins B and H have been identified. The gB protein is encoded by DNA in the HindIII F fragment of the HCMV genome lying between 1378 and 4095 bases from the F/D boundary. The gH protein is encoded by DNA in the HindIII L
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003US6610288 Isolated populations of such hepatocytes and methods for using the hepatocytes to treat subjects with disorders characterized by insufficient liver function are described. The porcine hepatocytes can be either hepatocytes isolated
08/26/2003US6610286 Administering interleukin antagonist
08/21/2003WO2003069342A1 A method of screening
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068959A1 Novel screening method
08/21/2003WO2003068956A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
08/21/2003WO2003068940A2 Complexes and methods of using same
1 ... 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 ... 1494